Document is current
Any future updates will be listed below
-
Authors
Pan, Meichen
O’Flaherty, Sarah
Hibberd, Ashley
Gerdes, Svetlana
Morovic, Wesley
Barrangou, Rodolphe
-
Funding
Funding for this research was provided by:
International Flavors & Fragrances
NC Ag Foundation
- License Information
-
More Information
Article History
Received: 17 June 2024
Accepted: 20 December 2024
First Online: 3 January 2025
Declarations
:
: Not applicable.
: Not applicable.
: R.B. is a cofounder of Intellia Therapeutics, Locus Biosciences, TreeCo, CRISPR Biotechnologies and Ancilia Biosciences, and a shareholder of Caribou Biosciences, CRISPRQC, KromaTiD, Raleigh Biosciences, Inari Ag, Felix Biotechnologies, Invaio, Tune Therapeutics, Hoofprint Biome, and Provaxus. M.P., S.O.F. and R.B. are co-inventors on patent applications related to probiotic uses. SG and AH are employees of IFF Inc. WM was an employee of IFF Inc at the time of data generation.
